You are here: Industry Insights > GSK

News List

ViiV’s fostemsavir shows promise in ‘heavily pre-treated’ HIV patients pharmatimes
November 05, 2018
ViiV Healthcare’s first-in-class attachment inhibitor fostemsavir has shown promise as a treatment for heavily pre-treated HIV patients failing on...
Long-term data backs safety and efficacy of GSK’s Nucala pharmatimes
November 05, 2018
GlaxoSmithKline has reported long-term safety data showing a sustained reduction in severe asthma attacks and improved asthma control ...
GSK announces two sets of positive results for HIV treatments pharmaceutical-technology
November 02, 2018
GlaxoSmithKline (GSK)’s human immunodeficiency virus (HIV) business ViiV Healthcare has announced positive results for two treatments for the virus.
GSK opens £54m API plant in Montrose, Scotland pharmafile
October 31, 2018
British multinational GlaxoSmithKline has opened an API manufacturing plant in Montrose Scotland for its Ellipta respiratory medicines.
The Global Pain Index – an insightful survey worldwide biospectrumasia
October 24, 2018
GSK Consumer Healthcare unveiled the Southeast Asia’s 2017 Global Pain Index (GPI) on 20th June 2017。
GSK to axe 99 positions at Memphis site pharmafile
October 19, 2018
GlaxoSmithKline’s workforce on President’s Island in Memphis, US, is set to see the loss of 99 employees, as revealed in a WARN notice filed with the State Department of Labor.
Cold-and-flu beverage to go? GSK launches Theraflu pods for coffee makers, backed by ad campaign fiercepharma
October 18, 2018
Instant brew cold-and-flu medicine? That’s GlaxoSmithKline's new distribution idea for Theraflu with single-use plastic pods that fit into Keurig and similar coffee makers. Theraflu PowerPods are hitting shelves now, supported ...
GSK updates its HCP payment policy pharmatimes
October 11, 2018
GlaxoSmithKline is overturning a blanket ban on payments to doctors promoting its medicines, now allowing the practice under certain circumstances.
New UK biopharma Sitryx launches with $30m fundraising pharmatimes
October 11, 2018
New UK biopharmaceutical group Sitryx has launched operations with $30 million to help it develop disease-modifying therapeutics in immunometabolism.
GSK to hold on to its antibiotics business, but nearly 200 workers will go fiercepharma
October 08, 2018
It has been a tough rollercoaster ride for GlaxoSmithKline’s U.K. manufacturing site in Ulverston. Once slated to get a major biologics plant with hundreds of new jobs, GSK is now closing a part of the plant and laying off nearly 200 workers.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page